Cargando…
Metformin Ameliorates Diabetic Cardiomyopathy by Activating the PK2/PKR Pathway
Diabetic cardiomyopathy (DCM) is a complication of diabetes that can cause damage to myocardial structure and function. Metformin (Met) is a widely used type 2 diabetes treatment drug that exerts cardioprotective effects through multiple pathways. Prokineticin 2 (PK2) is a small-molecule secreted pr...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252307/ https://www.ncbi.nlm.nih.gov/pubmed/32508669 http://dx.doi.org/10.3389/fphys.2020.00425 |